Cell therapies represent a promising new therapeutic modality that is expected to have a major impact on several serious disease conditions. However, the technologies and processes supporting the discovery and development of novel cell therapies are just taking shape and are likely to transform in the future.
Benchling provides a modern, fully configurable, and user-friendly platform that adapts to the rapidly evolving needs of cell therapy R&D. Benchling’s platform enables biopharmaceutical organizations to accelerate cell therapy R&D and bring more breakthrough therapies to market faster. With Benchling you can:
Manage a variety of cell-based entities and constructs including CAR-Ts, TCRs, and stem cells
- Design and analyze cell-based entities with sequence-level intelligence
- Map donor cells, vectors, genetic material, and final product relationships
- View complete experimental context of your cell therapy product lots
Edit the genome of novel targets, immunotherapies, cell lines, and stem cells
- Create and edit gRNA sequences with on/off-target scoring
- Manage your library of targeted nucleases
- Perform gene editing experiments
Integrate novel cell engineering methods and workflows
- Create custom workflows for specific cell engineering methods
- Have real-time visibility into your discovery process
- Modify your workflows without vendor involvement as program needs change
Read more